Basic information
Biomarker: CEP17
Biomarker subtype: DNA
Clinical application: prognosis(unfavorable)
Histology type: endometrial carcinoma
Cohort characteristics
Country: Italy
Region: Rome
Followed up time : 5 years
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 73 | EC | 73 |
Sample information
Sample type : tissue
Clinical method: (FISH) and immunohistochemistry (IHC)
Expression pattern : HER-2:CEP17 ratio > 4 < or = 5
Disease information
Related information
Description: In conclusion, molecular characteristics provide objective data that may be useful in predicting prognosis in patients with endometrial cancer.
